Group 1 - The core point of the article is that Maide Medical (688310) has proposed a share buyback plan, reflecting the confidence of its chairman in the company's future development and value [1] - As of November 27, 2025, Maide Medical's stock closed at 16.79 yuan, up 4.81% from the previous trading day, with a total market capitalization of 2.791 billion yuan [1] - The proposed buyback will utilize either excess funds or the company's own funds to repurchase A-shares, with a total amount between 20 million yuan and 40 million yuan, and a buyback price not exceeding 150% of the average trading price over the previous 30 trading days [1] Group 2 - The buyback period is set to be within 12 months from the date of approval by the shareholders' meeting [1] - The chairman, Lin Junhua, has committed to promoting the necessary review procedures and voting in favor of the proposal [1]
迈得医疗(688310)披露公司董事长、实际控制人提议公司回购股份的公告,11月27日股价上涨4.81%